Boost For Brain Cancer As Tocagen Enters EMA’s PRIME

 
• By Neena Brizmohun
  
Tumour
Tocagen's drug for glioma is now on the PRIME scheme • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Market Access

More from Pink Sheet